Seminar 4 – The Nordic Life Science Innovation Landscape

Fostering an environment in which medical innovation can thrive

Seminar 4 – The Nordic Life Science Innovation Landscape

17:15 - 18:15 Plenary Room A

Many ground-breaking life science innovations have their origin in the Nordics. Why is that? Can we utilize our developed ability to collaborate and exchange experiences to increase return on investment and develop our businesses further? In this thought-provoking and educational session, we will have a look at the Nordic life science innovation landscape. We will discuss different forms of collaborations forming a fostering environment for innovation. You’ll get a taste of exciting open innovation opportunities at LEO Pharma, and learn how RISE, the Research Institutes of Sweden, collaborate with Pfizer around new therapies. Also, find out where Nordic projects can reach global dimensions in collaboration with the US National Institutes of Health. A crucial part is of course how to do business of the collaboration, which will be a theme throughout our session.

Hosted by:

SwedenBIO

SwedenBIO

AWA

AWA

Moderator(s): Ms. Louise Jonshammar - Attorney At Law, AWA

Speaker(s):
Dr. Niclas Nilsson - Head of Open Innovation in Research, LEO Pharma Dr. Magnus Larsson - Vice President, Head of Unit Surface - Process and Formulation, RISE Dr. Ann-Charlotte Dorange - Health & Value Lead (Health Economics/HTA), Pfizer Dr. Michael L. Salgaller - Supervisor, Invention Development and Marketing Unit (IDMU), National Institutes of Health

full program